33.763.88% ( +1.26 )
Delay Closed: Oct 23, 15:00:00Current ValuationThe current P/E ratio is 9.80, below the reasonable range, cheaper than 91.03% of the time in the past 5 years, and the industry ranks 1/84, the industry Median 9.80.
9.8xP/E
¥33.76Stock price
¥3.45Earnings per share
9.8xP/E
Stock price¥33.76Earnings per share¥3.45
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 44.71x
- Typical range
- 19.03x–150.94x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 9.80x
0265278104
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 9.80x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
688331SHRemeGen | 9.81x | 486.37% | ¥57.11B |
688336SHSunshine Guojian Pharmaceutical | 9.80x | 78.00% | ¥30.26B |
688136SHSDKX | 19.60x | 21.52% | ¥4.10B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
